Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis
- PMID: 24755110
- DOI: 10.1016/j.healun.2014.02.032
Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis
Abstract
Background: Atrial arrhythmias (AAs) early after lung transplant are frequent and have a significant impact on morbidity and mortality. However, the pathogenesis of AAs after lung transplant remains incompletely understood. In this study we aimed to determine the prevalence of atrial fibrillation (AF) and other AAs, as well as risk factors, clinical outcomes and possible underlying mechanisms associated with AAs after lung transplant.
Methods: A retrospective analysis was performed on 382 patients who underwent lung transplantation from 2000 to 2010. A 12-lead electrocardiogram (ECG) was obtained and AAs classified as AF and other AAs (atrial flutter [AFL] and supraventricular tachycardia [SVT]). Multivariate logistic regression analysis was performed to determine predictors, and Kaplan-Meier survival curves were constructed.
Results: The incidence of AAs was 25%; 17.8% developed AF and 7.6% other AAs (AFL/SVT). The major indication for transplant was idiopathic pulmonary fibrosis (IPF, 35%). Significant predictors of AF were as follows: age; IPF; left atrial enlargement; diastolic dysfunction; and history of coronary artery disease (CAD). Risk factors for other AAs (AFL/SVT) were: age; right ventricle dysfunction; right ventricular enlargement; and elevated right atrial pressure (RAP). One-year mortality was higher in the arrhythmia group (21.5% arrhythmia vs 15.7% no-arrhythmia group; p < 0.05). In addition, patients treated with anti-arrhythmic medications had higher mortality (p < 0.05).
Conclusions: AAs are common after lung transplantation. Risk factors for developing either AF or other AAs (AFL/SVT) are different. The development of early AAs post-transplant is associated with prolonged post-operative stay and increased mortality. A rate-control strategy should be used as first-line therapy and anti-arrhythmic agents reserved for those patients who do not respond to the initial treatment.
Keywords: arrhythmias; atrial fibrillation; atrial flutter; lung transplant; risk factors.
Copyright © 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.J Heart Lung Transplant. 2006 Jan;25(1):53-60. doi: 10.1016/j.healun.2005.07.017. Epub 2005 Nov 2. J Heart Lung Transplant. 2006. PMID: 16399531
-
The prognostic significance of exercise-induced atrial arrhythmias.J Am Coll Cardiol. 2004 Apr 7;43(7):1236-40. doi: 10.1016/j.jacc.2003.10.054. J Am Coll Cardiol. 2004. PMID: 15063436
-
Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.Am J Cardiol. 2010 Sep 1;106(5):737-41. doi: 10.1016/j.amjcard.2010.04.035. Epub 2010 Jul 23. Am J Cardiol. 2010. PMID: 20723655
-
Management of arrhythmias in the emergency department.Cardiol Clin. 2006 Feb;24(1):125-33, vii. doi: 10.1016/j.ccl.2005.09.005. Cardiol Clin. 2006. PMID: 16326262 Review.
-
Incidence, Predictors, and Outcomes of Early Atrial Arrhythmias After Lung Transplant: A Systematic Review and Meta-Analysis.JACC Clin Electrophysiol. 2017 Jul;3(7):718-726. doi: 10.1016/j.jacep.2016.12.009. Epub 2017 Mar 1. JACC Clin Electrophysiol. 2017. PMID: 29759540
Cited by
-
Postoperative management of lung transplant recipients.J Thorac Dis. 2019 Sep;11(Suppl 14):S1782-S1788. doi: 10.21037/jtd.2019.05.60. J Thorac Dis. 2019. PMID: 31632755 Free PMC article. Review.
-
Pulmonary, circulatory and renal considerations in the early postoperative management of the lung transplant recipient.Glob Cardiol Sci Pract. 2023 Aug 1;2023(3):e202318. doi: 10.21542/gcsp.2023.18. eCollection 2023 Aug 1. Glob Cardiol Sci Pract. 2023. PMID: 37575284 Free PMC article. Review.
-
Late atrial tachycardia originating from donor pulmonary vein in a double lung transplant recipient.HeartRhythm Case Rep. 2015 Aug 17;1(6):490-493. doi: 10.1016/j.hrcr.2015.08.005. eCollection 2015 Nov. HeartRhythm Case Rep. 2015. PMID: 28491613 Free PMC article. No abstract available.
-
Clinical implication of electrocardiogram change in patients experiencing lung transplantation with end stage lung disease.Front Physiol. 2024 Oct 29;15:1440307. doi: 10.3389/fphys.2024.1440307. eCollection 2024. Front Physiol. 2024. PMID: 39539957 Free PMC article.
-
Impact of delayed veno-venous extracorporeal membrane oxygenation weaning on postoperative rehabilitation of lung transplantation: a single-center comparative study.J Artif Organs. 2023 Dec;26(4):303-308. doi: 10.1007/s10047-022-01376-7. Epub 2022 Dec 8. J Artif Organs. 2023. PMID: 36482123 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous